320 related articles for article (PubMed ID: 15790525)
1. Pathogenic effects of alpha-synuclein aggregation.
Lundvig D; Lindersson E; Jensen PH
Brain Res Mol Brain Res; 2005 Mar; 134(1):3-17. PubMed ID: 15790525
[TBL] [Abstract][Full Text] [Related]
2. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
Fujiwara H; Hasegawa M; Dohmae N; Kawashima A; Masliah E; Goldberg MS; Shen J; Takio K; Iwatsubo T
Nat Cell Biol; 2002 Feb; 4(2):160-4. PubMed ID: 11813001
[TBL] [Abstract][Full Text] [Related]
3. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein: normal function and role in neurodegenerative diseases.
Norris EH; Giasson BI; Lee VM
Curr Top Dev Biol; 2004; 60():17-54. PubMed ID: 15094295
[TBL] [Abstract][Full Text] [Related]
5. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
[TBL] [Abstract][Full Text] [Related]
6. The role of alpha-synuclein in neurodegenerative diseases.
Bennett MC
Pharmacol Ther; 2005 Mar; 105(3):311-31. PubMed ID: 15737408
[TBL] [Abstract][Full Text] [Related]
7. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
El-Agnaf OM; Irvine GB
J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein and transgenic mouse models.
Fernagut PO; Chesselet MF
Neurobiol Dis; 2004 Nov; 17(2):123-30. PubMed ID: 15474350
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein and neurodegenerative diseases.
Goedert M
Nat Rev Neurosci; 2001 Jul; 2(7):492-501. PubMed ID: 11433374
[No Abstract] [Full Text] [Related]
10. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
Popescu A; Lippa CF; Lee VM; Trojanowski JQ
Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
[TBL] [Abstract][Full Text] [Related]
11. Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells.
Matsuzaki M; Hasegawa T; Takeda A; Kikuchi A; Furukawa K; Kato Y; Itoyama Y
Brain Res; 2004 Apr; 1004(1-2):83-90. PubMed ID: 15033422
[TBL] [Abstract][Full Text] [Related]
12. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro.
McLean PJ; Klucken J; Shin Y; Hyman BT
Biochem Biophys Res Commun; 2004 Aug; 321(3):665-9. PubMed ID: 15358157
[TBL] [Abstract][Full Text] [Related]
13. Does cellular iron dysregulation play a causative role in Parkinson's disease?
Kaur D; Andersen J
Ageing Res Rev; 2004 Jul; 3(3):327-43. PubMed ID: 15231240
[TBL] [Abstract][Full Text] [Related]
14. Synucleins and their relationship to Parkinson's disease.
von Bohlen Und Halbach O
Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.
Iwata A; Maruyama M; Akagi T; Hashikawa T; Kanazawa I; Tsuji S; Nukina N
Hum Mol Genet; 2003 Oct; 12(20):2625-35. PubMed ID: 12928483
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.
Emadi S; Liu R; Yuan B; Schulz P; McAllister C; Lyubchenko Y; Messer A; Sierks MR
Biochemistry; 2004 Mar; 43(10):2871-8. PubMed ID: 15005622
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of alpha-synuclein and its significance].
Nonaka T; Iwatsubo T; Hasegawa M
Nihon Rinsho; 2004 Sep; 62(9):1623-8. PubMed ID: 15462375
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.
Paleologou KE; Irvine GB; El-Agnaf OM
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1106-10. PubMed ID: 16246056
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitration on the structure and aggregation of alpha-synuclein.
Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL
Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533
[TBL] [Abstract][Full Text] [Related]
20. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.
Duda JE; Giasson BI; Mabon ME; Lee VM; Trojanowski JQ
Ann Neurol; 2002 Aug; 52(2):205-10. PubMed ID: 12210791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]